Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancer

The Original Article was published on 07 November 2018

Correction to: Nature, published online 07 November 2018.

In this Letter, owing to an error in the production process, author Martin Aichinger was inadvertently associated with affiliation 14 (Karolinska Institute, Department of Medicine Solna, Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden) instead of affiliation 13 (Research Institute of Molecular Pathology, Vienna Biocenter, Campus-Vienna-Biocenter 1, Vienna, Austria). In addition, the chemical structure of QM385 in Fig. 3a was incorrect. Figure 1 of this Amendment shows the incorrect and corrected structures, for transparency. These errors have been corrected online.

Fig. 1
figure 1

This figure shows the incorrect and corrected structures of QM385 in Fig. 3a of the original Letter.

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Clifford J. Woolf or Josef M. Penninger.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cronin, S.J.F., Seehus, C., Weidinger, A. et al. Publisher Correction: The metabolite BH4 controls T cell proliferation in autoimmunity and cancer. Nature 572, E18 (2019).

Download citation

  • Published:

  • Issue Date:

  • DOI:


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing